222 related articles for article (PubMed ID: 22583829)
21. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance.
He W; Liu Q; Wang L; Chen W; Li N; Cao X
Mol Immunol; 2007 Apr; 44(11):2850-9. PubMed ID: 17328955
[TBL] [Abstract][Full Text] [Related]
22. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1.
Yang H; Young DW; Gusovsky F; Chow JC
J Biol Chem; 2000 Jul; 275(27):20861-6. PubMed ID: 10877845
[TBL] [Abstract][Full Text] [Related]
23. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
Wang L; Zhu R; Huang Z; Li H; Zhu H
Dig Dis Sci; 2013 Aug; 58(8):2223-36. PubMed ID: 23828139
[TBL] [Abstract][Full Text] [Related]
24. Expression and functional research of TLR4 in human colon carcinoma.
Tang XY; Zhu YQ; Wei B; Wang H
Am J Med Sci; 2010 Apr; 339(4):319-26. PubMed ID: 20228668
[TBL] [Abstract][Full Text] [Related]
25. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
Zhao W; Ma G; Chen X
Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment.
Han S; Xu W; Wang Z; Qi X; Wang Y; Ni Y; Shen H; Hu Q; Han W
Oncotarget; 2016 Jun; 7(25):37773-37789. PubMed ID: 27191981
[TBL] [Abstract][Full Text] [Related]
27. Lipopolysaccharide enhances OSCC migration by promoting epithelial-mesenchymal transition.
He Z; Deng R; Huang X; Ni Y; Yang X; Wang Z; Hu Q
J Oral Pathol Med; 2015 Oct; 44(9):685-92. PubMed ID: 25367215
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia attenuates inflammatory mediators production induced by Acanthamoeba via Toll-like receptor 4 signaling in human corneal epithelial cells.
Pan H; Wu X
Biochem Biophys Res Commun; 2012 Apr; 420(3):685-91. PubMed ID: 22450324
[TBL] [Abstract][Full Text] [Related]
29. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
30. Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4.
Wei X; Liu H; Li X; Liu X
Ann Hepatol; 2019; 18(6):869-878. PubMed ID: 31477445
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells.
Hsiao CC; Chen PH; Cheng CI; Tsai MS; Chang CY; Lu SC; Hsieh MC; Lin YC; Lee PH; Kao YH
Cancer Lett; 2015 Nov; 368(1):144-152. PubMed ID: 26276725
[TBL] [Abstract][Full Text] [Related]
32. Anesthetic agent propofol inhibits myeloid differentiation factor 88-dependent and independent signaling and mitigates lipopolysaccharide-mediated reactive oxygen species production in human neutrophils in vitro.
Ren X; Lv F; Fang B; Liu S; Lv H; He G; Ma H; Cao Y; Wang Y
Eur J Pharmacol; 2014 Dec; 744():164-72. PubMed ID: 25446563
[TBL] [Abstract][Full Text] [Related]
33. Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-κDa Laminin Receptor and the TLR4/MAPK/NF-κB Signalling Pathway in Lipopolysaccharide-Induced Macrophages.
Li YF; Wang H; Fan Y; Shi HJ; Wang QM; Chen BR; Khurwolah MR; Long QQ; Wang SB; Wang ZM; Wang LS
Cell Physiol Biochem; 2017; 43(3):926-936. PubMed ID: 28957799
[TBL] [Abstract][Full Text] [Related]
34. GEF-H1/RhoA signalling pathway mediates lipopolysaccharide-induced intercellular adhesion molecular-1 expression in endothelial cells via activation of p38 and NF-κB.
Guo F; Zhou Z; Dou Y; Tang J; Gao C; Huan J
Cytokine; 2012 Mar; 57(3):417-28. PubMed ID: 22226621
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
36. CerS6 regulates cisplatin resistance in oral squamous cell carcinoma by altering mitochondrial fission and autophagy.
Li S; Wu Y; Ding Y; Yu M; Ai Z
J Cell Physiol; 2018 Dec; 233(12):9416-9425. PubMed ID: 30054909
[TBL] [Abstract][Full Text] [Related]
37. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.
Jakus PB; Kalman N; Antus C; Radnai B; Tucsek Z; Gallyas F; Sumegi B; Veres B
J Nutr Biochem; 2013 May; 24(5):819-23. PubMed ID: 22925919
[TBL] [Abstract][Full Text] [Related]
38. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways.
Gorina R; Font-Nieves M; Márquez-Kisinousky L; Santalucia T; Planas AM
Glia; 2011 Feb; 59(2):242-55. PubMed ID: 21125645
[TBL] [Abstract][Full Text] [Related]
39. Role of nucleotide-binding oligomerization domain 1 (NOD1) in pericyte-mediated vascular inflammation.
Navarro R; Delgado-Wicke P; Nuñez-Prado N; Compte M; Blanco-Toribio A; Nuñez G; Álvarez-Vallina L; Sanz L
J Cell Mol Med; 2016 May; 20(5):980-6. PubMed ID: 26915562
[TBL] [Abstract][Full Text] [Related]
40. STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma.
Naher L; Kiyoshima T; Kobayashi I; Wada H; Nagata K; Fujiwara H; Ookuma YF; Ozeki S; Nakamura S; Sakai H
Int J Oncol; 2012 Nov; 41(5):1577-86. PubMed ID: 22922995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
